Prediction of prognostic biomarkers for interferon-based therapy to hepatitis C virus patients: a meta-analysis of the NS5A protein in subtypes 1a, 1b, and 3a

Hepatitis C virus (HCV) is a worldwide health problem with no vaccine and the only approved therapy is Interferon-based plus Ribavarin. Response prediction to treatment has health and economic impacts, and is a multi-factorial problem including both host and viral factors (e.g: age, sex, ethnicity,...

Full description

Bibliographic Details

Published in:	Virology journal Vol. 7; p. 130
Main Authors:	ElHefnawi, Mahmoud M, Zada, Suher, El-Azab, Iman A
Format:	Journal Article
Language:	English
Published:	England 15-06-2010
Subjects:	Amino Acid Sequence Antiviral Agents - therapeutic use Biomarkers Hepacivirus - classification Hepacivirus - genetics Hepatitis C - diagnosis Hepatitis C - drug therapy Humans Interferons - therapeutic use Molecular Sequence Data Mutation Ribavirin - therapeutic use Viral Nonstructural Proteins - chemistry Viral Nonstructural Proteins - genetics
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!